Participated · Series A · Aug 2022

Founded in 2022 by Joey Levy and Jake Paul, Betr operates at the intersection of real-money gaming and sports media. The company’s flagship product, Betr Picks, debuted in September 2023 and has already attracted several hundreds of thousands of paying users across 33 states and Washington, D.C. In 2024 it added Betr Arcade, now live in 29 states, and it plans to roll out additional nationwide gaming offerings within the same app in 2025 to further diversify its product suite. Betr complements its gaming platform with original media programming that drives user engagement and acquisition. By integrating high-profile personalities and tailored content, the firm seeks to blur the lines between wagering, entertainment, and fan communities. Its strategy relies on leveraging the large social footprints of partners and creators to amplify reach and lower customer-acquisition costs. Although specific revenue figures were not disclosed, the rapid user growth and expanding product roadmap underscore the company’s ambition to become a leading consumer brand in U.S. real-money gaming.

Participated · Seed · Nov 2021

Narrative BI offers a no-code, user-oriented business intelligence platform that combines visual interfaces, natural language narratives, and advanced anomaly detection to make analytics accessible to non-technical growth teams. The platform consolidates product and marketing data from sources such as Mixpanel, Google Analytics, and HubSpot and transforms raw signals into shareable insights. It integrates collaborative features like Slack delivery to help teams spot issues early and distribute narratives quickly. Narrative BI emphasizes self-service reporting with no IT involvement, aiming to reduce reliance on engineering and legacy analytics stacks. The company soft-launched a public beta in August 2021 and reports it has already extracted insights from customer data derived from millions of unique users. Narrative BI plans to use its new capital to continue product development and expand its augmented-analytics capabilities for product-led companies.

Participated · Series A · Jun 2019

Flo Health is a London-based fertility-focused period-tracking app offering cycle and ovulation tracking, symptom monitoring (users can track over 70 symptoms), and personalized health insights. The company says it has served some 380 million users globally, with about 70 million monthly active users on its free product and roughly 5 million paid subscribers. Flo monetizes through premium subscriptions and intends to keep subscriptions as its core business model. The company plans to expand features for perimenopause and menopause, continue integrations with devices like Apple Watch, and may pursue acquisitions to grow inorganically. Flo highlights its privacy and security posture, noting a settled 2021 FTC investigation and dual ISO certifications (ISO 27001 and ISO 27701). Founded in 2015 by Dmitry Gurski and his twin brother, Flo operates from London with a major hub in Vilnius and runs a pro-social program that provides free premium access in 66 countries, benefiting nearly 16 million women. Flo Health, Inc. announced it received $49.704991 million in funding. The investment was provided by VNV Global AB and Target Germanium GmbH. The transaction closed on September 9, 2021. The Series B round was led by Target Germanium GmbH and included new investor VNV Global AB (publ). The funding was raised at a post-money valuation of $800,000,000. The article does not disclose operating metrics, product details, or future plans. Flo Health is a Belarusian women's health app with broad reach: about 10% of women aged 15–40 in Europe and the US use Flo. The company introduced monetization in early 2019 and says it doubled active audience year-over-year with average monthly revenue growth of 30%. Flo is described as the most popular and commercially successful product in its category. Today the company employs 140 specialists in the CIS and plans to grow headcount to 200 by year-end. Management says investments will be directed at further product development and team growth. Following the extension, Flo's valuation rose to $230 million. Flo Health develops Flo, a women's health product that combines a neural-network-based period and ovulation calendar, a personalized content feed, and anonymous social/group chat functionality. The app targets females across life stages (menstruation start, cycle tracking, conception, pregnancy, early motherhood, menopause) and emphasizes safety and trusted health information. Flo makes intensive use of data science and AI to deliver personalized content and services and is available in 22 languages on iOS and Android. Launched in October 2015, the app has been downloaded over 70 million times and reports 28 million monthly users; the user base grows by about 4.5 million downloads monthly. Flo is the number one female health product by active audience in the U.S. (per App Annie) and has sizable penetration in over 100 countries, with 60% of users in the U.S. and Europe. Company leadership cites ambitions to scale further and leverage investor partnerships for product and market expansion across Asian, European, and American markets. Flo Health develops Flo, an AI-driven women's health app that provides cycle tracking, conception preparation, pregnancy support, early motherhood tools and menopause care. Since its October 2015 launch the app has been downloaded over 60 million times and records 22 million monthly active users, with installs growing by about 4.5 million per month. Over 4 million women have become pregnant using Flo, a figure that the company says is increasing by roughly 500,000 per month. Flo uses neural networks and proprietary AI algorithms to improve cycle predictions, detect concerning symptoms, and deliver personalized guidance and prompts to seek medical care. The company employs 100+ specialists (around 70% women), offers the tracker in 22 languages, and reports roughly 60% of users are in the US and Europe. Flo aims to reach 100 million monthly active users, build a large anonymous women's community, and expand scientific and research partnerships to advance personalization and medical credibility.

Participated · Seed · Nov 2018

Founded in 2015, Miami-based Knack offers a student success platform that enables colleges and universities to identify, credential, and pay high-achieving students who serve as peer tutors for their classmates. The software handles tutor recruitment, matching, scheduling, and payment, giving institutions a turnkey way to expand academic support services while creating paid, skill-building jobs for students. Knack is already deployed on hundreds of U.S. campuses, with partners that include Fordham University, Northeastern University, the University of Florida, and Georgia Tech. Through these partnerships, student tutors on the platform have collectively earned millions of dollars and schools report improvements in retention and graduation rates. The company plans to use fresh capital to deepen campus penetration and further scale its peer-learning programs. Veteran education executive Megan Dusenbery, formerly Chief Partnerships Officer at ACUE, has been appointed CEO to steer this next growth phase, while founder Samyr Qureshi moves to Executive Chairman. Knack is backed by a roster of education-focused investors such as New Markets Venture Partners, Precursor Ventures, ETS.org, Chegg, ASU Enterprise Partners, Village Capital, and Bisk Ventures.